Calidi Starts High-Grade Glioma Trial Recruitment
Calidi Biotherapeutics has begun enrolling patients at Northwestern University/Northwestern Memorial Hospital for a clinical trial of CLD-101, an immunotherapy...
Brain Exercise Lowers Fatigue in MS Study
Researchers at New York University (NYU) found that brain exercises from the BrainHQ app, developed by Posit Science, reduced...
Leti-101 Shows Promise in Preclinical Huntington’s Disease Study
ElevateBio has unveiled preclinical data for LETI-101, a CRISPR-based therapy for Huntington’s Disease (HD) being developed by its subsidiary,...
FDA Grants Auron Therapeutics Fast Track Designation for AUTX-703 to Treat AML
Auron Therapeutics received FDA Fast Track designation for AUTX-703, an oral KAT2A/B degrader, for treating relapsed or refractory acute...
Preparing and Upskilling the Clinical Trial Workforce for AI Innovation
The 2025 SCOPE Summit’s fireside chat focused on how companies are preparing and upskilling their clinical trial workforce to...
Duvakitug Shows Promise in Ulcerative Colitis and Crohn’s Disease
Teva Pharmaceuticals and Sanofi announced positive Phase 2b results for duvakitug, a novel antibody targeting TL1A, in patients with...
Samsung Bioepis Launches Stelara® Biosimilar Pyzchiva® in US
Samsung Bioepis launched PYZCHIVA (ustekinumab-ttwe), a biosimilar to Stelara, in the United States. The drug is approved to treat...
Clinical Trial Budget Negotiation Discussion Sheds Light on Inefficiency
At the SCOPE Summit 2025 Conference, a panel discussion titled “Redesigning Site Contract and Clinical Trial Budget Negotiations to...
Komen Calls for Urgent Action on Racial Disparities in Breast Cancer
New data reveals that Black women in the U.S. have a significantly higher mortality rate from breast cancer than...
EG 427 Gets €27M in Series B Funding for Clinical Study
EG 427, a biotech company developing targeted genetic medicines for neurological conditions, secured €27 million in Series B funding....